Second Sight Medical Products, Inc. Stock price
Is Second Sight Medical Products, Inc. a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?
As a Free StocksGuide user, you can view scores for all 9,127 stocks worldwide.
Key metrics
Second Sight Medical Products, Inc. Stock Analysis
Analyst Opinions
10 Analysts have issued a Second Sight Medical Products, Inc. forecast:
Analyst Opinions
10 Analysts have issued a Second Sight Medical Products, Inc. forecast:
Don't miss a Thing! We will send you all news about Second Sight Medical Products, Inc. directly to your mailbox free of charge.
If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.
Second Sight Medical Products, Inc. Stock News
Company Profile
Second Sight Medical Products, Inc. engages in the development, manufacture, and marketing of implantable visual prosthetics. It operates through the following geographical segments: United States, Italy, France, and China. The firm's product include Argus II Retinal Prosthesis System that treats outer retinal degenerations, such as retinitis pigmentosa, also referred to as RP. The company was founded by Alfred E. Mann, Aaron Mendelsohn, Sam Williams, Robert J. Greenberg, and Gunnar Bjorg in 1998 and is headquartered in Sylmar, CA.
| Head office | United States |
| CEO | Dr. Mendelsohn |
| Employees | 42 |
| Founded | 2003 |
| Website | vivani.com |


